4/A//SEC Filing
Gallagher Patrick Stephen 4/A
Accession 0001209191-23-021540
CIK 0001829802other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 5:13 PM ET
Size
9.8 KB
Accession
0001209191-23-021540
Insider Transaction Report
Form 4/AAmended
Gallagher Patrick Stephen
Chief Business Officer
Transactions
- Award
Common Stock
2023-02-15+14,200→ 43,513 total - Award
Stock Option (Right to Buy)
2023-02-15+60,000→ 60,000 totalExercise: $1.43Exp: 2023-02-14→ Common Stock (60,000 underlying) - Award
Common Stock
2023-02-15+29,313→ 29,313 total
Footnotes (4)
- [F1]This amendment is being filed solely to correct the number of shares beneficially owned, which the original filing overreported by two shares.
- [F2]These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs are fully vested.
- [F3]These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in four equal annual installments on each of February 15, 2024, February 15, 2025, February 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such date.
- [F4]The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2024, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001932215
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 5:13 PM ET
- Size
- 9.8 KB